Insights+: COVID-19 Healthcare News Monthly Updates - August 2020
- Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it
- The outbreak of the respiratory disease was first detected in Wuhan City, Hubei Province, China in Dec 2019
- PharmaShots is keeping a track of all of the important updates in the Life-sciences sector, where we have covered news updates regarding collaborations, clinical trials, funding, and regulatory guidelines related to the COVID-19 from Jan to date
83. GSK and VIR Biotechnology Initiate P-II/III COMET-ICE Study of VIR-7831 Against COVID-19
Aug 31, 2020 | Clinical Trial
Aug 31, 2020 | Clinical Trial
81. Johnson & Johnson Collaborates with the Government of Canada to Supply its Ad26.COV2.S for COVID-19
Aug 31, 2020 | Clinical Trial
80. BeiGene Signs an Exclusive License Agreement with Singlomics for Neutralizing COVID-19 Antibodies
Aug 27, 2020 | Collaboration
79. Abbott's BinaxNOW COVID-19 Ag Card Receives the US FDA's EUA to Detect SARS-CoV-2 Infection
Aug 27, 2020 | Diagnostics
78. Laurent Pharmaceuticals Receives Approval from FDA to Initiate its COVID-19 Phase 2 Clinical Trial in the United States
Aug 27, 2020 | Regulatory
77. FDC Launches Two Variants of Favipiravir for COVID-19 in India
Aug 27, 2020 | Launch
76. Q BioMed Initiates GMP Production of Novel COVID-19 Therapeutic for Clinical Trial Program
Aug 26, 2020 | Clinical Trial
75. INTAS Develops COVID-19 Hyperimmune Globulin
Aug 26, 2020 | Regulatory
74. Capricor Therapeutics Report the US FDA Acceptance of its IND Application for a Phase 2 Clinical Trial of CAP-1002 in Patients with COVID-19
Aug 25, 2020 | Regulatory
73. AstraZeneca Initiates P-I Study of AZD7442 Against COVID-19
Aug 25, 2020 | Clinical Trial
72. Bolder BioTechnology Announces Positive Preclinical Data for Use of BBT-032 to Inhibit Growth of the SARS-CoV-2 Virus
Aug 25, 2020 | Clinical Trial
71. Asalyxa Bio Launches with Novel Neutrophil-Targeting Drug Delivery Platform Technology and Lead Candidate, ASX-100 for ARDS and COVID-19 Patients
Aug 25, 2020 | Launch
70. Biovista Harnesses New Kinds of Augmented and Artificial Intelligence to Address COVID-19
Aug 25, 2020 | DigiHealth
69. EpiVax Announces Licensing of COVID-19 Vaccine Candidate to EpiVax Therapeutics
Aug 25, 2020 | Collaboration
68. Mereo BioPharma Initiates P-Ib/II Clinical Trial with Alvelestat in COVID-19 Respiratory Disease
Aug 25, 2020 | Clinical Trial
67. Altimmune and the University of Alabama at Birmingham Report Potent Respiratory Mucosal T Cell Responses in Preclinical Study of Single-Dose Intranasal COVID-19 Vaccine Candidate, AdCOVID
Aug 25, 2020 | Clinical Trial
66. Partner Therapeutics Initiates Patient Enrollment in US Clinical Trial Evaluating Leukine (rhuGM-CSF, sargramostim) in COVID-19 Patients
Aug 25, 2020 | Clinical Trial
65. First Rapid Corona Antigen Test Approved for Clinical Study in Germany
Aug 25, 2020 | Diagnostics
64. Flexibility, Speed Enabling Actifio to Help in Pursuit of COVID-19 Treatments
Aug 25, 2020 | DigiHealth
63. Kedrion Biopharma and Kamada Continue Their Collaboration to Develop a New Anti-COVID Plasma-Based Treatment
Aug 25, 2020 | Collaboration
62. UNION therapeutics Completes Dosing of Healthy Volunteers with UNI911 (inhaled niclosamide) for COVID-19
Aug 25, 2020 | Clinical Trial
61. Medicure AGGRASTAT Shows Promise in Treating Thrombotic Complications Due to COVID-19 in Early Clinical Reports
Aug 25, 2020 | Clinical Trial
60. Terumo and Cytosorbent Collaborate to Commercialize CytoSorb in Ten US COVID-19 Hotspot States
Aug 25, 2020 | Collaboration
59. Pfizer and BioNTech Plan for Regulatory Review of its COVID-19 Vaccine in October 2020
Aug 21, 2020 | Regulatory
58. BioSymetrics Signs an Agreement with Janssen and Sema4 to Utilize AI for the Prediction of COVID-19
Aug 20, 2020 | Collaboration
57. Sorrento Files IND for STI-1499 (COVI-GUARD) in Patients Hospitalized with COVID-19
Aug 20, 2020 | Regulatory
56. Qiagen Launches QIAseq SARS-CoV-2 Primer Panel for Tracking COVID-19 Mutations and Strains
Aug 20, 2020 | Launch
55. Fitbit Reports Results of its COVID-19 Study for Early Detection of Diseases
Aug 20, 2020 | DigiHealth
54. Finding Clues to a Successful Immune Response in the T Cells of Recovered COVID-19 Patients
Aug 21, 2020 | Clinical Trial
53. JanOne to Discuss JAN101 for Treatment of PAD and Potential Applications for COVID-19 Vascular Complications
Aug 21, 2020 | Clinical Trial
52. Co-Diagnostics Receives Enhanced U.S. Patent Protection for CoPrimer Technology Used in COVID-19 Test
Aug 20, 2020 | Diagnostics
51. Clinical Research Trials Underway to Study COVID-19 Impact on Dialysis Patients
Aug 20, 2020 | Clinical Trial
50. LumiraDx Receives FDA Emergency Use Authorization for Point of Care COVID-19 Antigen Test
Aug 20, 2020 | Diagnostics
49. Zymo Research Granted CE IVD Mark for Quick SARS-CoV-2 rRT-PCR Kit
Aug 20, 2020 | Diagnostics
48. Regeneron Collaborates with Roche to Improve the Global Supply of REGN-COV2 Against COVID-19
Aug 19, 2020 | Collaboration
47. Hackensack Meridian Health Observational Study Identifies Drug that Improves Survival in Sickest COVID-19 Patients
Aug 19, 2020 | Clinical Trial
46. Bio-Techne and Leica Biosystems Accelerates Disease Research with RNAscope COVID-19 Probes and the BOND RX
Aug 19, 2020 | Clinical Trial
45. Ampio Provides Update on COVID-19 Clinical Trial Activities
Aug 19, 2020 | Clinical Trial
44. Harbour BioMed, Utrecht University, Erasmus Medical Center, Viroclinics-DDL and Kiadis Pharma Collaborate to Develop Monoclonal Antibody for COVID-19
Aug 19, 2020 | Collaboration
43. NIH Delivers $4.3 Million to Support Convalescent Plasma Clinical Trial
Aug 18, 2020 | Grant
42. AstraZeneca Collaborates with mAbxience to Produce COVID-19 Vaccine in Latin America
Aug 18, 2020 | Collaboration
41. Vnada's Interim Analysis from ODYSSEY Study Shows Tradipitant may Accelerate Clinical Improvement in Patients with COVID-19 Pneumonia
Aug 18, 2020 | Clinical Trial
40. BOLD-100 Significantly Outperforms Remdesivir Head-to-Head in SARS-CoV-2 (COVID-19) Model
Aug 17, 2020 | Clinical Trial
39. Pharming Announces the Publication of Data from a Compassionate Use Programme of RUCONEST in COVID-19 patients in a Peer-Reviewed Journal
Aug 17, 2020 | Clinical Trial
38. Novavax Collaborates with UK Government to Supply 60M Doses of NVX-CoV2373 to Combat COVID-19
Aug 14, 2020 | Collaboration
37. SK bioscience Collaborate with Novavax to Supply Antigen for COVID-19 Vaccine
Aug 14, 2020 | Collaboration
36. EC Concludes Exploratory Talks with J&J to Supply 200M Doses of COVID-19 Vaccine
Aug 14, 2020 | Collaboration
35. AstraZeneca to Initiate Production of its COVID-19 Vaccine Early in 2021
Aug 14, 2020 | Clinical Trial
34. Algernon Announces Enrollment of First U.S. Patient in Multinational Phase 2b/3 Human Study of Ifenprodil for Treatment of COVID-19
Aug 13, 2020 | Clinical Trial
33. UNION Therapeutics Enters Option Agreement to Acquire Worldwide Exclusive License for COVID-19 Technologies Developed by TFF Pharmaceuticals
Aug 13, 2020 | Collaboration
32. Anixa and OntoChem Announce Identification of Additional Covid-19 Compounds
Aug 13, 2020 | Collaboration
31. Alphabet's Verily Establishes CLIA-Certified Lab Focusing on COVID-19 Testing
Aug 13, 2020 | Diagnostics
30. Zydus Launches Cheapest Version of Remdesivir at $37.41 per Vial in India
Aug 13, 2020 | Launch
29. Puradigm Announces Successful Tests of its Proactive Air and Surface Purification Technology in Deactivating SARS-CoV-2
Aug 10, 2020 | Diagnostics
28. New Study Proves Asclepius Meditec's Hydrogen Oxygen Generator Helps Improve COVID-19 Disease Severity and Dyspnea
Aug 10, 2020 | Diagnostics
27. Vela Diagnostics ViroKey SARS-CoV-2 RT-PCR Test Receives the US FDA's Emergency Use Authorization
Aug 07, 2020 | Diagnostics
26. Daiichi Sankyo Selected as Provider for Japanese Government's Emergent Initiative to Build Production Capacity for COVID-19 Vaccines
Aug 07, 2020 | Collaboration
25. Serum Institute to Produce COVID-19 Vaccines From AstraZeneca, Novavax
Aug 07, 2020 | Collaboration
24. Amarin Supports Study of Vascepa in Reducing Viral Upper Respiratory Infection
Aug 07, 2020 | Clinical Trial
23. Covistat, Biopharmaceutical Company Developing Low-Cost COVID-19 Treatment Acquires IP From World Leader in Respiratory Disease Medicine
Aug 06, 2020 | Collaboration
22. Moderna Prices its COVID-19 Vaccine at $32-$37 per Dose for Smaller Volume Agreements
Aug 06, 2020 | Collaboration
21. Johnson & Johnson Signs an Agreement with the US Government to Supply 100M Doses of COVID-19 Vaccine Worth ~$1B
Aug 06, 2020 | Collaboration
20. Glenmark Introduces FabiFlu (400mg) to Reduce Pill Burden of COVID-19 Treatment
Aug 06, 2020 | Launch
19. NIH Begins Clinical Trial Testing of Remdesivir + Interferon Beta-1a for COVID-19
Aug 06, 2020 | Clinical Trial
18. SAB Biotherapeutics Awarded $35.6M from U.S. Department of Defense for COVID-19 and Scaling Rapid Response Antibody Program
Aug 06, 2020 | Grant
17. Pfizer AND BioNTech To Supply BNT162 mRNA- based Vaccine Candidate in Canada
Aug 05, 2020 | Collaboration
16. Revive Therapeutics Update Following U.S. FDA Approval of Phase 3 Clinical Trial for Bucillamine in COVID-19
Aug 05, 2020 | Regulatory
15. Texas Startup Industrial Genetics Launches Surface and Wastewater Testing for the COVID-19 Virus (SARS-CoV-2)
Aug 05, 2020 | Launch
14. Zydus Cadila Announces Completion of Dosing in Phase I Clinical Trial of ZyCoV-D
Aug 05, 2020 | Clinical Trial
13. Centex Studies-Lake Charles to be the Only Site in SWLA to Run AstraZeneca COVID Vaccine Clinical Trial
Aug 05, 2020 | Clinical Trial
12. Celularity Announces the Activation of first California Clinical Trial Site following CIRM Grant Award to Advance Treatments for COVID-19
Aug 05, 2020 | Grant
11. Lupin and SunPharma Launch Generic Favipiravir to Treat Mild to Moderate COVID-19 in India
Aug 05, 2020 | Launch
10. BioNTech and Fosun Pharma Initiate Clinical Trial of BNT162b1 Against COVID-19 in China
Aug 05, 2020 | Clinical Trial
9. Eli Lilly in Collaboration with NIAID Initiate P-III Study of LY-CoV555 to Prevent COVID-19
Aug 04, 2020 | Collaboration
8. Sanofi and GSK Receive $2.1B from the US Government to Supply 100M Doses of COVID-19 Vaccine
Aug 04, 2020 | Grant
7. Tiziana Life Sciences Expedite Clinical Development Plan for TZLS-501 for COVID-19
Aug 04, 2020 | Clinical Trial
6. Novavax Reports Positive Early Results for Experimental COVID-19 Vaccine NVX-CoV2373
Aug 04, 2020 | Clinical Trial
5. VERU-111 Suppresses Key Cytokines Responsible for Severe Acute Respiratory Distress Syndrome in COVID-19
Aug 04, 2020 | Clinical Trial
4. Angion Enrolls First Patients in Phase 2 Clinical Trial of ANG-3777 in Patients with Acute Lung Injury Associated with COVID-19 Pneumonia
Aug 04, 2020 | Clinical Trial
3. Innovation Pharmaceuticals and US Regional Biocontainment Laboratory Nearing Completion of Brilacidin Anti-SARS-CoV-2 (COVID-19) In Vitro Testing
Aug 04, 2020 | Diagnostic
2. Neutrolis Announces Development Of First-In-Class Treatment Targeting Neutrophil Extracellular Traps (NETs) For Patients With Severe COVID-19
Aug 03, 2020 | Clinical Trial
1. Rival Drugmakers Launch Joint Trial of Medicines for COVID-19
Aug 03, 2020 | Clinical Trial
Related Post: Insights+: COVID-19 Healthcare News Monthly Updates - September 2020
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com